Advertisement
U.S. markets close in 1 hour 23 minutes

Novartis AG (NVS)

NYSE - Nasdaq Real Time Price. Currency in USD
Visitors trend2W10W9M
103.55+0.01 (+0.01%)
As of 02:37PM EST. Market open.
Full screen
Loading interactive chart...
  • Zacks

    FDA Begins Review of Alnylam's sNDA for Expanded Amvuttra Use

    ALNY reports submitting an sNDA in the United States, seeking the label expansion of Amvuttra to treat ATTR amyloidosis with cardiomyopathy.

  • TipRanks

    Novartis to present data from mpre than 65 abstracts as ASH, SABCS

    Novartis (NVS) will present data from more than 65 abstracts, including investigator-initiated trials at the 66th American Society of Hematology, ASH, Annual Meeting & Exposition and the 2024 San Antonio Breast Cancer Symposium, SABCS. Longer-term 96-week results from Scemblix ASC4FIRST Phase III study in first-line Ph+ CML-CP to be presented following recent FDA approval based on 48-week data. Late-breaking Kisqali 4-year analysis on distant disease-free survival in key subgroups with HR+/HER2-